Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 309-496-6 | CAS number: 100402-60-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-07-02 to 2007-09-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline Study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- December 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- D-Glucose, ether with glycerol
- EC Number:
- 309-496-6
- EC Name:
- D-Glucose, ether with glycerol
- Cas Number:
- 100402-60-6
- Molecular formula:
- C9H18O8, small ammounts of C15H28O13 and C21H38O18 (UVCB)
- IUPAC Name:
- (3R,4S,5S,6R)-2-(2,3-dihydroxypropoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; (3R,4S,5S,6R)-2-(3-hydroxy-2-{[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; (3R,4S,5S,6R)-2-[2,3-bis({[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH; D-97633 Sulzfeld
- Age at study initiation: no data
- Weight at study initiation: 166 - 177 g
- Fasting period before study: over night
- Housing: transparent macrolon cages (type 3-180, floor area 810 sq.cm), two or three animals in each cage;
- Diet: pelleted complete rodent diet, Altromin 1314; Altromin GmbH, D-32791 Lage, Lippe, Germany
- Water: domestic quality drinking water, acidified with hydrochloric acid to pH 2.5 in order to prevent microbial growth
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity: at least30 %; not exceeding 70 %
- Air changes: 10 times per hour
- Photoperiod: 12 hours light, 12 hours dark from 6 am to 6 pm
IN-LIFE DATES: From: 2007-07-03 To: 2007-07-24
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test item was administered orally by gavage to rats fasted over night prior to dosing. After dosing diet was witheld for 4 more hours. Dosing in the study took place on July 4th, 2007 between 7:10 and 7.20 am and on July 10th, 2007 between 9:00 and 9.10 am.
The study was carried out with two groups consisting of three female animals each given a dose of 2000 mg/kg bw. The start of the first group was on July 3rd, 2007. The start of the second group was on July 9th, 2007.
The dose volume administered was 10 mL/kg bw. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 2 dose groups of 3 females per dose group
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: Each rat was observed 30 min, 2, 4 and 6 hours after administration of the test item and thereafter daily for aperiod of 14 days
- Frequency of observations and weighing: observations: daily; weighing : on day 0, 7, and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- NA
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Neither animals of the first group nor of the second group died on account of the treatment nor did they show severe signs of toxicosis.
- Clinical signs:
- other: First group; female: Animals No.1, No.2 and No. 3 showed piloerection 30 min and 2 hours after the application of the test item. After 4 hours and 6 hoursas well as from day 1 to the end of the observation period on day 14 no abnormalities were observed.
- Gross pathology:
- The gross necropsy revealed no pathological abnormalities.
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance was not toxic after oral application.
- Executive summary:
The test substance was investigated for its oral toxicity in accordance with OECD guideline 423 in female rats. No deaths occured until the end of the 14 day observation period. Only minimal and transient indisposition was observed during the first 4 hours after application. the test substance is not toxic after oral application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
